About Qingxi Wang
Form D filings for Neurock Pharmaceuticals in 2024 list Qingxi Wang as director.
Qingxi Wang first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Qingxi Wang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Qingxi Wang works with at each company, as listed on that company's latest Form D.
Neurock Pharmaceuticals Inc. · Form D, Mar 11, 2024
HW
Haixing Wang
Executive officer
LC
Lei Cai
CEO